Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 0.00 (-2.12%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Change in Receivables (2010 - 2012)

Updated

Vistagen Therapeutics' Change in Receivables was -$40,600 in fiscal Q2 2022 (quarter ended Sep 30, 2021).

Analysis

Vistagen Therapeutics (VTGN) Change in Receivables (2010 - 2012) Analysis & Trends

For FY2013 (ended Mar 31, 2013), Change in Receivables at Vistagen Therapeutics came in at $106,200.

  • In earlier fiscal years, Change in Receivables was -$64,000 in FY2012 and $205,000 in FY2011.
  • The fiscal Q2 2022 figure marks the highest quarterly Change in Receivables since fiscal Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Vistagen Therapeutics 8.39 Mn -207.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 106,200.00
Mar 31, 2012 -98,400.00
Dec 31, 2011 119,200.00
Sep 30, 2011 21,500.00
Jun 30, 2011 -106,300.00
Mar 31, 2011 196,773.00
Dec 31, 2010 -189,646.00
Sep 30, 2010 841.00
Jun 30, 2010 197,032.00
API Access

Vistagen Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=VTGN&period=max&api_key=YOUR_API_KEY